Detailed information for compound 178924

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 541.68 | Formula: C33H39N3O4
  • H donors: 4 H acceptors: 3 LogP: 4.26 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCCC(=O)NCCc1ccc2c(c1)c1C[C@@]3(O)C4Cc5c6[C@]3([C@H](c1[nH]2)Oc6c(O)cc5)CCN4CC1CC1
  • InChi: 1S/C33H39N3O4/c1-2-3-4-27(38)34-13-11-19-7-9-24-22(15-19)23-17-33(39)26-16-21-8-10-25(37)30-28(21)32(33,31(40-30)29(23)35-24)12-14-36(26)18-20-5-6-20/h7-10,15,20,26,31,35,37,39H,2-6,11-14,16-18H2,1H3,(H,34,38)/t26?,31-,32-,33+/m0/s1
  • InChiKey: XNAWXRGPRKPPIN-NHTBSUTASA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens opioid receptor, mu 1 Starlite/ChEMBL References
Homo sapiens opioid receptor, kappa 1 Starlite/ChEMBL References
Homo sapiens opioid receptor, delta 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus tm gpcr rhodopsin Get druggable targets OG5_139759 All targets in OG5_139759
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily Get druggable targets OG5_139759 All targets in OG5_139759

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus CoRest homolog 0.0526 0.8265 1
Loa Loa (eye worm) hypothetical protein 0.0511 0.8024 0.9708
Loa Loa (eye worm) hypothetical protein 0.0526 0.8265 1
Plasmodium vivax hypothetical protein 0.0015 0 0.5
Brugia malayi Myb-like DNA-binding domain containing protein 0.0511 0.8024 1
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily 0.0634 1 1
Schistosoma mansoni zinc finger protein 0.0015 0 1

Activities

Activity type Activity value Assay description Source Reference
Ke (binding) = 0.23 nM Ability to displace DPDPE from human recombinant Opioid receptor delta 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ke (binding) = 0.23 nM Ability to displace DPDPE from human recombinant Opioid receptor delta 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ke (binding) = 0.46 nM Ability to displace U-69,593 from human recombinant Opioid receptor kappa 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ke (binding) = 0.46 nM Ability to displace U-69,593 from human recombinant Opioid receptor kappa 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ke (binding) = 3.37 nM Ability to displace DAMGO from human recombinant Opioid receptor mu 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ke (binding) = 3.37 nM Ability to displace DAMGO from human recombinant Opioid receptor mu 1 in CHO cells using [35S]- GTPgama S Assay ChEMBL. 12519069
Ki (binding) = 0.68 nM Ability to displace [3H]-U69,593 from human recombinant Opioid receptor kappa 1 in CHO cells ChEMBL. 12519069
Ki (binding) = 0.68 nM Ability to displace [3H]-U69,593 from human recombinant Opioid receptor kappa 1 in CHO cells ChEMBL. 12519069
Ki (binding) = 7.67 nM Ability to displace [3H]-DPDPE from human recombinant Opioid receptor delta 1 in CHO cells ChEMBL. 12519069
Ki (binding) = 7.67 nM Ability to displace [3H]-DPDPE from human recombinant Opioid receptor delta 1 in CHO cells ChEMBL. 12519069
Ki (binding) = 31.59 nM Ability to displace [3H]-DAMGO from human recombinant Opioid receptor mu 1 in CHO cells ChEMBL. 12519069
Ki (binding) = 31.59 nM Ability to displace [3H]-DAMGO from human recombinant Opioid receptor mu 1 in CHO cells ChEMBL. 12519069
Ratio (binding) = 0.5 Selectivity between delta receptor and kappa receptor ChEMBL. 12519069
Ratio (binding) = 7 Selectivity between mu receptor and kappa receptor ChEMBL. 12519069
Ratio (binding) = 11 Selectivity between delta receptor and kappa receptor ChEMBL. 12519069
Ratio (binding) = 46 Selectivity between mu receptor and kappa receptor ChEMBL. 12519069

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.